The CFC [Catalyst for a Cure] funding made it possible for me to transition half my laboratory into the study of glaucoma and neural repair and
ganglion cell repair and regeneration.
Not exact matches
So for the last 15 years I've been studying retinal
ganglion cell biology trying to understand why they fail to survive after injury or in degenerative diseases like glaucoma and also when their connections to the brain are interrupted why do they fail to regenerate to regrow, why do they fail to
repair themselves, it's this fundamental problem that leads to permanent vision loss in glaucoma.
His laboratory at Stanford University School of Medicine is developing novel stem
cell and nanotherapeutics approaches for ocular
repair, studying retinal
ganglion cell development, survival and axon regeneration in glaucoma, and investigating the cellular basis for the developmental loss of axon growth ability.